Advanced search
Publication Cover
Modern Rheumatology Volume 29, 2019 - Issue 3
Journal homepage
201
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis

Tetsuya FurukawaDivision of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan;
,
Kiyoshi MatsuiDivision of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan; Correspondence[email protected]
,
Masayasu KitanoDivision of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan;
,
Yuichi YokoyamaDivision of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan;
,
Masahiro SekiguchiDivision of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan;
,
Naoto AzumaDivision of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan;
,
Yasutomo ImaiDepartment of Dermatology, Hyogo College of Medicine, Hyogo, Japan;
,
Seiichi HirotaDepartment of Surgical Pathology, Hyogo College of Medicine, Hyogo, Japan
,
Kiyofumi YamanishiDepartment of Dermatology, Hyogo College of Medicine, Hyogo, Japan;
&
Hajime SanoDivision of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan;
show all
Pages 476-483 | Received 25 Jan 2018, Accepted 05 Apr 2018, Published online: 06 Sep 2018

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Valentin Dichev, Nikolay Hristov Mehterov, Maria Hristova Kazakova, Rositsa Valerieva Karalilova, Anastas Zgurov Batalov & Victoria Stepan Sarafian. (2021) Serum protein levels of YKL-40 and plasma miR-214 expression in patients with systemic sclerosis. Modern Rheumatology 31:5, pages 1010-1018.
Read now
Yi Kong, Suhan Zhang, Xin Su, Daoquan Peng & Yuwen Su. (2019) Serum levels of YKL-40 are increased in patients with psoriasis: a meta-analysis. Postgraduate Medicine 131:6, pages 405-412.
Read now

Articles from other publishers (7)

Andrea-Hermina Györfi, Tim Filla, Nicholas Dickel, Florian Möller, Yi-Nan Li, Christina Bergmann, Alexandru-Emil Matei, Thomas Harrer, Meik Kunz, Georg Schett & Jörg H W Distler. (2023) Performance of serum biomarkers reflective of different pathogenic processes in systemic sclerosis-associated interstitial lung disease. Rheumatology.
Crossref
Ming Tang, Dongyang Zhou, Junhui He, Hongying Bai, Qianqian Li & Hui Xu. (2023) Chitinase-3 like-protein-1, matrix metalloproteinase -9 and positive intracranial arterial remodelling. Frontiers in Aging Neuroscience 15.
Crossref
Xiuna Sun, Erika Nakajima, Carmelissa Norbrun, Parand Sorkhdini, Alina Xiaoyu Yang, Dongqin Yang, Corey E. Ventetuolo, Julie Braza, Alexander Vang, Jason Aliotta, Debasree Banerjee, Mandy Pereira, Grayson Baird, Qing Lu, Elizabeth O. Harrington, Sharon Rounds, Chun Geun Lee, Hongwei Yao, Gaurav Choudhary, James R. Klinger & Yang Zhou. (2022) Chitinase 3 like 1 contributes to the development of pulmonary vascular remodeling in pulmonary hypertension. JCI Insight 7:18.
Crossref
Suh-Young Lee, Chang-Min Lee, Bing Ma, Suchitra Kamle, Jack A. Elias, Yang Zhou & Chun Geun Lee. (2022) Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis. Frontiers in Pharmacology 13.
Crossref
Sebastian Majewski, Karolina Szewczyk, Hanna Jerczyńska, Joanna Miłkowska-Dymanowska, Adam J. Białas, Łukasz Gwadera & Wojciech J. Piotrowski. (2022) Longitudinal and Comparative Measures of Serum Chitotriosidase and YKL-40 in Patients With Idiopathic Pulmonary Fibrosis. Frontiers in Immunology 13.
Crossref
Miruna Carnaru & Monique Hinchcliff. (2021) Soluble Biomarkers for Prediction of Vascular and Gastrointestinal Disease Severity in Patients with Systemic Sclerosis. Current Treatment Options in Rheumatology 7:1, pages 21-38.
Crossref
Xiang Tong, Yao Ma, Tao Liu, Zhenzhen Li, Sitong Liu, Guihui Wu & Hong Fan. (2021) Can YKL-40 be used as a biomarker for interstitial lung disease?. Medicine 100:17, pages e25631.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.